Estimating blood volume in obese and morbidly obese patients.
about
Physiological and management implications of obesity in critical illnessA Review of the Toxicologic Implications of ObesityAssessing metal exposures in a community near a cement plant in the Northeast U.SObesity in the intensive care unit: risks and complications.Human organ/tissue growth algorithms that include obese individuals and black/white population organ weight similarities from autopsy data.Designing drug regimens for special intensive care unit populations.A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMIMeasurement of Blood Volume in Adult Rhesus Macaques (Macaca mulatta).Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese womenMathematical model to interpret localized reflectance spectra measured in the presence of a strong fluorescence markerDose correction for post-contrast T1 mapping of the heart: the MESA study.Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome.MMP-2 gene polymorphisms are associated with type A aortic dissection and aortic diameters in patients.The effects of obesity on drug pharmacokinetics in humans.Fixed Dosing of Monoclonal Antibodies in Oncology.The association between the time from oxytocin cessation during labour to Cesarean delivery and postpartum blood loss: a retrospective cohort study.[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer.Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy.The effect of obesity and repeated exposure on pharmacokinetic response to grape polyphenols in humans.Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications.Adjustment of target weight based on absolute blood volume reduces the frequency of intradialytic morbid events.Hemodialysis Ultrafiltration Rate Targets Should Be Scaled to Body Surface Area Rather than to Body Weight.Anti-Xa Levels 4 h After Subcutaneous Administration of 5,700 IU Nadroparin Strongly Correlate with Lean Body Weight in Morbidly Obese Patients.Cardiac response to exercise in normal-weight and obese, Hispanic men and women: implications for exercise prescription.Influence of Body Mass Index on the Activated Clotting Time Under Weight-Based Heparin Dose.Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint.Lean-scaled weight can be used to estimate blood volume for obese patients.A Novel Approach to Predict 24-Hour Energy Expenditure Based on Hematologic Volumes: Development and Validation of Models Comparable to Mifflin-St Jeor and Body Composition Models.Pharmacokinetics of Sucralose and Acesulfame-Potassium in Breast Milk Following Ingestion of Diet Soda.A BMI >35 does not protect patients undergoing cardiac bypass surgery from red blood cell transfusion.Role of donor and recipient sex in platelet transfusion.Blood volume measurement by hemodilution: association with valve disease and re-evaluation of the Allen Formula.
P2860
Q26830471-6C6AB3FD-2851-4077-A0ED-5B8797BDE06BQ28082947-174B4FBF-AA55-4BD0-863B-C352B95FF94EQ28651523-FAAEE7A8-B8D9-477C-BD68-E51CFAF145FEQ30251547-2351B7F8-541B-438B-A9C7-E04F11B7114CQ33415589-A59F0A68-0C67-4582-B982-0B6F4EDF9928Q35544079-5114E615-4971-48F1-A70F-C951A57671D2Q36205202-3A13C76C-4877-41C2-BFD5-C9547DFBC2AAQ36352238-03558D22-C2CB-46C7-97B4-25A898BAF8CFQ36354286-373C9EFD-9CC7-4673-A1EE-98D8D8484E9EQ36526263-445A7B41-BD0E-4268-B385-E6E8997852D2Q36540551-DAE005A3-9D90-4364-B191-36785BD4A333Q37103661-B2300374-9DA1-4BDF-B055-F609D6A3414EQ37364998-4F4A899D-2F9D-4281-B15B-37497A9DD1ADQ37854751-222C4560-A839-4B45-AFD3-32706EEE8252Q38654371-F227E3CC-6739-4C33-A309-9C8A97FCD59AQ38831096-3ABEDA31-1584-4B8F-B4C1-7ECD415DB626Q39794283-B43D2D8B-D494-4863-9256-37847D61ABBAQ44871715-A6739E87-A0AB-4AC5-A162-55F23279757BQ44873488-0C46B15D-22E3-4E87-8D2C-D6CF6B82B436Q45051137-6925DC02-B477-44FD-94B9-23EC86A416EDQ47197029-0ADC7C36-6A64-4020-A520-C5FD529D6DCDQ47246573-365A2BF4-4DCC-47EE-B9CE-70E4CCE30CF7Q47328313-9A00651A-54EE-4F39-AA66-99CE581E4006Q47350858-BB0A1E42-DFA5-44DA-80ED-0F38E5C9C652Q47424028-AF38D182-AF56-402D-9200-F8A3D94CC005Q47431339-7A14C8A2-03D3-41A3-B486-C9D45C0280EFQ47444574-8DD56FC0-65D3-4F81-91A9-A1E69E17FF39Q47820946-C4EDE7DA-7EA7-41D0-8AFF-11A719C175A3Q47873020-A5D6EFD4-6280-49F4-A2B8-A8663A6021D7Q50235169-8DB66DA4-0E9A-4BCD-BDC8-920D623BBDAFQ50494399-697C766E-4D01-40CC-ADF8-6E12FB455E24Q51055771-79666CC5-4A67-47FB-996E-48C80094DB91
P2860
Estimating blood volume in obese and morbidly obese patients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Estimating blood volume in obese and morbidly obese patients.
@en
Estimating blood volume in obese and morbidly obese patients.
@nl
type
label
Estimating blood volume in obese and morbidly obese patients.
@en
Estimating blood volume in obese and morbidly obese patients.
@nl
prefLabel
Estimating blood volume in obese and morbidly obese patients.
@en
Estimating blood volume in obese and morbidly obese patients.
@nl
P2093
P1433
P1476
Estimating blood volume in obese and morbidly obese patients.
@en
P2093
Donald P Bernstein
Harry J M Lemmens
Jay B Brodsky
P2888
P304
P356
10.1381/096089206777346673
P577
2006-06-01T00:00:00Z
P6179
1047809603